POLICY PAPER - COST Exploratory Workshop on Pharmacology and Toxicology of the Blood-Brain Barrier: State of the Art, Needs for Future Research and Expected Benefits for the EU (CROSBI ID 590274)
Prilog sa skupa u zborniku | izvorni znanstveni rad
Podaci o odgovornosti
Kapitulnik, J ; Hammarlund-Udenaes, M ; Gundert-Remy, U ; Kostelidou, K ; Crichton, R ; Žarković, N ; Boobis, AR
engleski
POLICY PAPER - COST Exploratory Workshop on Pharmacology and Toxicology of the Blood-Brain Barrier: State of the Art, Needs for Future Research and Expected Benefits for the EU
There is a growing need for CNS-active therapies, requiring the development of medications that are able to reach and penetrate the desired regions of the brain. This last has proven to be problematical, as the brain is protected very effectively against exogenous substances. Its major line of defense is the blood-brain barrier (BBB). This barrier is a dynamic interface between the body and the brain, which is actively engaged in the regulatory functions of the CNS and helps in maintaining a healthy steady state.
blood-brain barrier; CNS
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
2010.
objavljeno
Podaci o matičnoj publikaciji
Pharmacology and Toxicology of the Blood-Brain Barrier: State of the Art, Needs for Future Research and Expected Benefits for the EU
Podaci o skupu
Pharmacology and Toxicology of the Blood-Brain Barrier : State of the Art, Needs for Future Research and Expected Benefits for the EU
predavanje
11.02.2010-12.02.2010
Bruxelles, Belgija